Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016723 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-07 | 2023-03-04+ | TEVA | Weiss Amir | CAO | M - OptEx | — | +16.6K | 41.2K | +68% | — |
| D | 2023-03-07 | 2023-03-03 | TEVA | Weiss Amir | CAO | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 |
| DM | 2023-03-07 | 2023-03-04+ | TEVA | Weiss Amir | CAO | M - OptEx | $0.00 | -16.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-03-04 | M | A | 2,406 | — | 26,964.41 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 2 | Common | Ordinary Shares | 2023-03-04 | M | A | 10,676 | — | 37,640.41 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Common | Ordinary Shares | 2023-03-05 | M | A | 3,564 | — | 41,204.41 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 4 | Derivative | Restricted Share Units | 2023-03-03 | A | A | 20,717 | $0.00 | 20,717 | D | — · — to — | 20,717 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F3) Restricted share units were granted on March 3, 2023, with 5,179 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 5,180 vesting on March 3, 2027. |
| 5 | Derivative | Restricted Share Units | 2023-03-05 | M | D | 3,564 | $0.00 | 7,130 | D | — · — to — | 3,564 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F6) Restricted share units were granted on March 5, 2021, with 3,564 vested on each of March 5, 2022 and March 5, 2023, 3,564 vesting on March 5, 2024, and 3,566 vesting on March 5, 2025. |
| 6 | Derivative | Restricted Share Units | 2023-03-04 | M | D | 10,676 | $0.00 | 32,031 | D | — · — to — | 10,676 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on March 4, 2022, with 10,676 vested on March 4, 2023, 10,676 vesting on each of March 4, 2024 and March 4, 2025, and 10,679 vesting on March 4, 2026. |
| 7 | Derivative | Restricted Share Units | 2023-03-04 | M | D | 2,406 | $0.00 | 0 | D | — · — to — | 2,406 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on March 4, 2019, with 2,403 vested on each of March 4, 2021 and March 4, 2022, and 2,406 vested on March 4, 2023. |